Eagle Pharmaceuticals
EGRX
#11130
Rank
ยฃ2.5 M
Marketcap
ยฃ0.19
Share price
0.00%
Change (1 day)
-79.97%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): ยฃ28.7 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ0.25 Billion. In 2022 the company made an earning of ยฃ50.17 Million, an increase over its 2021 earnings that were of -ยฃ2.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) ยฃ28.7 M-42.8%
2022 ยฃ50.17 M-2361.45%
2021 -ยฃ2.22 Million-111.53%
2020 ยฃ19.23 M2.31%
2019 ยฃ18.8 M-32.89%
2018 ยฃ28.01 M-50.35%
2017 ยฃ56.42 M38.63%
2016 ยฃ40.7 M1966.43%
2015 ยฃ1.96 M-111.46%
2014 -ยฃ17.2 Million282.82%
2013 -ยฃ4.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.25 B 52,400.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ9.62 B 35,355.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ26.48 B 97,404.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.41 B 30,893.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.63 B 31,678.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ5.44 B 19,963.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ0.93 B 3,332.51%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel